Report Detail

Pharma & Healthcare Global Medical Hydroxyapatite Market Insights, Forecast to 2028

  • RnM4398592
  • |
  • 15 March, 2022
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Summary:

Market Analysis and Insights: Global Medical Hydroxyapatite Market
Due to the COVID-19 pandemic, the global Medical Hydroxyapatite market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Hydroxyapatite Paste accounting for % of the Medical Hydroxyapatite global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Orthopedic segment is altered to an % CAGR throughout this forecast period.
China Medical Hydroxyapatite market size is valued at US$ million in 2021, while the US and Europe Medical Hydroxyapatite are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical Hydroxyapatite landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Medical Hydroxyapatite include FLUIDINOVA, Merz North America, Inc, Himed, CaP Biomaterials, SofSera, Bio-Rad, Bonesupport AB, GE Healthcare and Sigma Graft, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Hydroxyapatite Paste
Hydroxyapatite Powder
Hydroxyapatite Particles
Segment by Application
Orthopedic
Dental Care
Others
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Medical Hydroxyapatite market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
FLUIDINOVA
Merz North America, Inc
Himed
CaP Biomaterials
SofSera
Bio-Rad
Bonesupport AB
GE Healthcare
Sigma Graft
Berkeley Advanced Biomaterials
Zimmer Biomet
Nano Interface Technology
Frequently Asked Questions
Which is the most lucrative product segment in the Medical Hydroxyapatite market?
Which are the prominent strategies of the Medical Hydroxyapatite market players?
Which factors are increasing the competition in the Medical Hydroxyapatite market?
Which are the recommendations provided by the Medical Hydroxyapatite industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Medical Hydroxyapatite market growth?
Which product segment will register the fastest growth rate in the Medical Hydroxyapatite market?
Which emerging trends will impact the Medical Hydroxyapatite market growth?
Which are the high-impact rendering factors in the Medical Hydroxyapatite market?
Which companies will maintain their lead on the Medical Hydroxyapatite market?


Table of Contents

    1 Study Coverage

    • 1.1 Medical Hydroxyapatite Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Medical Hydroxyapatite Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Hydroxyapatite Paste
      • 1.2.3 Hydroxyapatite Powder
      • 1.2.4 Hydroxyapatite Particles
    • 1.3 Market by Application
      • 1.3.1 Global Medical Hydroxyapatite Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Orthopedic
      • 1.3.3 Dental Care
      • 1.3.4 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Medical Hydroxyapatite Sales Estimates and Forecasts 2017-2028
    • 2.2 Global Medical Hydroxyapatite Revenue Estimates and Forecasts 2017-2028
    • 2.3 Global Medical Hydroxyapatite Revenue by Region: 2017 VS 2021 VS 2028
    • 2.4 Global Medical Hydroxyapatite Sales by Region
      • 2.4.1 Global Medical Hydroxyapatite Sales by Region (2017-2022)
      • 2.4.2 Global Sales Medical Hydroxyapatite by Region (2023-2028)
    • 2.5 Global Medical Hydroxyapatite Revenue by Region
      • 2.5.1 Global Medical Hydroxyapatite Revenue by Region (2017-2022)
      • 2.5.2 Global Medical Hydroxyapatite Revenue by Region (2023-2028)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Medical Hydroxyapatite Sales by Manufacturers
      • 3.1.1 Global Top Medical Hydroxyapatite Manufacturers by Sales (2017-2022)
      • 3.1.2 Global Medical Hydroxyapatite Sales Market Share by Manufacturers (2017-2022)
      • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Hydroxyapatite in 2021
    • 3.2 Global Medical Hydroxyapatite Revenue by Manufacturers
      • 3.2.1 Global Medical Hydroxyapatite Revenue by Manufacturers (2017-2022)
      • 3.2.2 Global Medical Hydroxyapatite Revenue Market Share by Manufacturers (2017-2022)
      • 3.2.3 Global Top 10 and Top 5 Companies by Medical Hydroxyapatite Revenue in 2021
    • 3.3 Global Medical Hydroxyapatite Sales Price by Manufacturers (2017-2022)
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Medical Hydroxyapatite Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Medical Hydroxyapatite Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Medical Hydroxyapatite Sales by Type
      • 4.1.1 Global Medical Hydroxyapatite Historical Sales by Type (2017-2022)
      • 4.1.2 Global Medical Hydroxyapatite Forecasted Sales by Type (2023-2028)
      • 4.1.3 Global Medical Hydroxyapatite Sales Market Share by Type (2017-2028)
    • 4.2 Global Medical Hydroxyapatite Revenue by Type
      • 4.2.1 Global Medical Hydroxyapatite Historical Revenue by Type (2017-2022)
      • 4.2.2 Global Medical Hydroxyapatite Forecasted Revenue by Type (2023-2028)
      • 4.2.3 Global Medical Hydroxyapatite Revenue Market Share by Type (2017-2028)
    • 4.3 Global Medical Hydroxyapatite Price by Type
      • 4.3.1 Global Medical Hydroxyapatite Price by Type (2017-2022)
      • 4.3.2 Global Medical Hydroxyapatite Price Forecast by Type (2023-2028)

    5 Market Size by Application

    • 5.1 Global Medical Hydroxyapatite Sales by Application
      • 5.1.1 Global Medical Hydroxyapatite Historical Sales by Application (2017-2022)
      • 5.1.2 Global Medical Hydroxyapatite Forecasted Sales by Application (2023-2028)
      • 5.1.3 Global Medical Hydroxyapatite Sales Market Share by Application (2017-2028)
    • 5.2 Global Medical Hydroxyapatite Revenue by Application
      • 5.2.1 Global Medical Hydroxyapatite Historical Revenue by Application (2017-2022)
      • 5.2.2 Global Medical Hydroxyapatite Forecasted Revenue by Application (2023-2028)
      • 5.2.3 Global Medical Hydroxyapatite Revenue Market Share by Application (2017-2028)
    • 5.3 Global Medical Hydroxyapatite Price by Application
      • 5.3.1 Global Medical Hydroxyapatite Price by Application (2017-2022)
      • 5.3.2 Global Medical Hydroxyapatite Price Forecast by Application (2023-2028)

    6 North America

    • 6.1 North America Medical Hydroxyapatite Market Size by Type
      • 6.1.1 North America Medical Hydroxyapatite Sales by Type (2017-2028)
      • 6.1.2 North America Medical Hydroxyapatite Revenue by Type (2017-2028)
    • 6.2 North America Medical Hydroxyapatite Market Size by Application
      • 6.2.1 North America Medical Hydroxyapatite Sales by Application (2017-2028)
      • 6.2.2 North America Medical Hydroxyapatite Revenue by Application (2017-2028)
    • 6.3 North America Medical Hydroxyapatite Market Size by Country
      • 6.3.1 North America Medical Hydroxyapatite Sales by Country (2017-2028)
      • 6.3.2 North America Medical Hydroxyapatite Revenue by Country (2017-2028)
      • 6.3.3 United States
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Medical Hydroxyapatite Market Size by Type
      • 7.1.1 Europe Medical Hydroxyapatite Sales by Type (2017-2028)
      • 7.1.2 Europe Medical Hydroxyapatite Revenue by Type (2017-2028)
    • 7.2 Europe Medical Hydroxyapatite Market Size by Application
      • 7.2.1 Europe Medical Hydroxyapatite Sales by Application (2017-2028)
      • 7.2.2 Europe Medical Hydroxyapatite Revenue by Application (2017-2028)
    • 7.3 Europe Medical Hydroxyapatite Market Size by Country
      • 7.3.1 Europe Medical Hydroxyapatite Sales by Country (2017-2028)
      • 7.3.2 Europe Medical Hydroxyapatite Revenue by Country (2017-2028)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Medical Hydroxyapatite Market Size by Type
      • 8.1.1 Asia Pacific Medical Hydroxyapatite Sales by Type (2017-2028)
      • 8.1.2 Asia Pacific Medical Hydroxyapatite Revenue by Type (2017-2028)
    • 8.2 Asia Pacific Medical Hydroxyapatite Market Size by Application
      • 8.2.1 Asia Pacific Medical Hydroxyapatite Sales by Application (2017-2028)
      • 8.2.2 Asia Pacific Medical Hydroxyapatite Revenue by Application (2017-2028)
    • 8.3 Asia Pacific Medical Hydroxyapatite Market Size by Region
      • 8.3.1 Asia Pacific Medical Hydroxyapatite Sales by Region (2017-2028)
      • 8.3.2 Asia Pacific Medical Hydroxyapatite Revenue by Region (2017-2028)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America Medical Hydroxyapatite Market Size by Type
      • 9.1.1 Latin America Medical Hydroxyapatite Sales by Type (2017-2028)
      • 9.1.2 Latin America Medical Hydroxyapatite Revenue by Type (2017-2028)
    • 9.2 Latin America Medical Hydroxyapatite Market Size by Application
      • 9.2.1 Latin America Medical Hydroxyapatite Sales by Application (2017-2028)
      • 9.2.2 Latin America Medical Hydroxyapatite Revenue by Application (2017-2028)
    • 9.3 Latin America Medical Hydroxyapatite Market Size by Country
      • 9.3.1 Latin America Medical Hydroxyapatite Sales by Country (2017-2028)
      • 9.3.2 Latin America Medical Hydroxyapatite Revenue by Country (2017-2028)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina
      • 9.3.6 Colombia

    10 Middle East and Africa

    • 10.1 Middle East and Africa Medical Hydroxyapatite Market Size by Type
      • 10.1.1 Middle East and Africa Medical Hydroxyapatite Sales by Type (2017-2028)
      • 10.1.2 Middle East and Africa Medical Hydroxyapatite Revenue by Type (2017-2028)
    • 10.2 Middle East and Africa Medical Hydroxyapatite Market Size by Application
      • 10.2.1 Middle East and Africa Medical Hydroxyapatite Sales by Application (2017-2028)
      • 10.2.2 Middle East and Africa Medical Hydroxyapatite Revenue by Application (2017-2028)
    • 10.3 Middle East and Africa Medical Hydroxyapatite Market Size by Country
      • 10.3.1 Middle East and Africa Medical Hydroxyapatite Sales by Country (2017-2028)
      • 10.3.2 Middle East and Africa Medical Hydroxyapatite Revenue by Country (2017-2028)
      • 10.3.3 Turkey
      • 10.3.4 Saudi Arabia

    11 Company Profiles

    • 11.1 FLUIDINOVA
      • 11.1.1 FLUIDINOVA Corporation Information
      • 11.1.2 FLUIDINOVA Overview
      • 11.1.3 FLUIDINOVA Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.1.4 FLUIDINOVA Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.1.5 FLUIDINOVA Recent Developments
    • 11.2 Merz North America, Inc
      • 11.2.1 Merz North America, Inc Corporation Information
      • 11.2.2 Merz North America, Inc Overview
      • 11.2.3 Merz North America, Inc Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.2.4 Merz North America, Inc Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.2.5 Merz North America, Inc Recent Developments
    • 11.3 Himed
      • 11.3.1 Himed Corporation Information
      • 11.3.2 Himed Overview
      • 11.3.3 Himed Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.3.4 Himed Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.3.5 Himed Recent Developments
    • 11.4 CaP Biomaterials
      • 11.4.1 CaP Biomaterials Corporation Information
      • 11.4.2 CaP Biomaterials Overview
      • 11.4.3 CaP Biomaterials Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.4.4 CaP Biomaterials Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.4.5 CaP Biomaterials Recent Developments
    • 11.5 SofSera
      • 11.5.1 SofSera Corporation Information
      • 11.5.2 SofSera Overview
      • 11.5.3 SofSera Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.5.4 SofSera Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.5.5 SofSera Recent Developments
    • 11.6 Bio-Rad
      • 11.6.1 Bio-Rad Corporation Information
      • 11.6.2 Bio-Rad Overview
      • 11.6.3 Bio-Rad Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.6.4 Bio-Rad Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.6.5 Bio-Rad Recent Developments
    • 11.7 Bonesupport AB
      • 11.7.1 Bonesupport AB Corporation Information
      • 11.7.2 Bonesupport AB Overview
      • 11.7.3 Bonesupport AB Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.7.4 Bonesupport AB Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.7.5 Bonesupport AB Recent Developments
    • 11.8 GE Healthcare
      • 11.8.1 GE Healthcare Corporation Information
      • 11.8.2 GE Healthcare Overview
      • 11.8.3 GE Healthcare Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.8.4 GE Healthcare Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.8.5 GE Healthcare Recent Developments
    • 11.9 Sigma Graft
      • 11.9.1 Sigma Graft Corporation Information
      • 11.9.2 Sigma Graft Overview
      • 11.9.3 Sigma Graft Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.9.4 Sigma Graft Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.9.5 Sigma Graft Recent Developments
    • 11.10 Berkeley Advanced Biomaterials
      • 11.10.1 Berkeley Advanced Biomaterials Corporation Information
      • 11.10.2 Berkeley Advanced Biomaterials Overview
      • 11.10.3 Berkeley Advanced Biomaterials Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.10.4 Berkeley Advanced Biomaterials Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.10.5 Berkeley Advanced Biomaterials Recent Developments
    • 11.11 Zimmer Biomet
      • 11.11.1 Zimmer Biomet Corporation Information
      • 11.11.2 Zimmer Biomet Overview
      • 11.11.3 Zimmer Biomet Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.11.4 Zimmer Biomet Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.11.5 Zimmer Biomet Recent Developments
    • 11.12 Nano Interface Technology
      • 11.12.1 Nano Interface Technology Corporation Information
      • 11.12.2 Nano Interface Technology Overview
      • 11.12.3 Nano Interface Technology Medical Hydroxyapatite Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.12.4 Nano Interface Technology Medical Hydroxyapatite Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.12.5 Nano Interface Technology Recent Developments

    12 Industry Chain and Sales Channels Analysis

    • 12.1 Medical Hydroxyapatite Industry Chain Analysis
    • 12.2 Medical Hydroxyapatite Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Medical Hydroxyapatite Production Mode & Process
    • 12.4 Medical Hydroxyapatite Sales and Marketing
      • 12.4.1 Medical Hydroxyapatite Sales Channels
      • 12.4.2 Medical Hydroxyapatite Distributors
    • 12.5 Medical Hydroxyapatite Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Medical Hydroxyapatite Industry Trends
    • 13.2 Medical Hydroxyapatite Market Drivers
    • 13.3 Medical Hydroxyapatite Market Challenges
    • 13.4 Medical Hydroxyapatite Market Restraints

    14 Key Findings in The Global Medical Hydroxyapatite Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Summary:
      Get latest Market Research Reports on Medical Hydroxyapatite. Industry analysis & Market Report on Medical Hydroxyapatite is a syndicated market report, published as Global Medical Hydroxyapatite Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Medical Hydroxyapatite market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,358.20
      6,716.40
      4,002.00
      8,004.00
      662,635.50
      1,325,271.00
      365,965.50
      731,931.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report